MitraClip to the Rescue in Cardiogenic Shock

Al‐Hijji, Mohammed; Ahmed, AshrafOmer Elamin; Mohammed, Nazar; Alzaeem, HakamAbdallah; Jalil, SyedMuhammad Saad; Maaly, CheikhAbdoul

doi:10.4103/heartviews.heartviews_87_22

Cited by 2 publications

(3 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…There were 7 case series and 5 observational studies. [11][12][13][18][19][20][21][22][23][24][25][26][27] We included a total population of 4060 CS patients who underwent TEER.…”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Transcatheter edge‐to‐edge mitral valve repair for mitral regurgitation in patients with cardiogenic shock: A systematic review and meta‐analysis

Saito,

Kuno,

Ueyama

et al. 2023

Cathet Cardio Intervent

View full text Add to dashboard Cite

BackgroundThere is currently little evidence for transcatheter edge‐to‐edge mitral valve repair (TEER) for mitral regurgitation (MR) in patients with cardiogenic shock (CS). Therefore, this study investigated the characteristics and outcomes of CS patients who underwent TEER for MR.MethodsPubMed, EMBASE were searched in July 2023. Case series and observational studies reporting clinical characteristics and outcomes in CS patients with MR who underwent TEER were included. We performed a one‐group meta‐analysis using a random effects model.ResultsA total of 4060 patients from 7 case series and 5 observational studies were included. The mean age was 68.2 (95% confidence interval [CI]: 64.1–72.2) years, and 41.4% of patients (95% CI: 39.1%–43.7%) were female. Pre‐TEER, severe MR was present in 85.3% (95% CI: 76.1%–91.3%) of patients. Mean left ventricular ejection fraction was 36.7% (95% CI: 29.2%–44.2%), and 54.6% (95% CI: 36.9%–71.2%) of patients received mechanical circulatory support. The severity of MR post‐TEER was less than 2+ in 88% (95% CI: 87%–89%) of patients. In‐hospital mortality was 11% (95% CI: 10%–13%), whereas 30‐day and 1‐year mortality rates were 15% (95% CI: 13%–16%), and 36% (95% CI: 21%–54%), respectively.ConclusionsThis systematic review and meta‐analysis assessed the clinical characteristics and outcomes of TEER in CS patients with MR. TEER for MR in patients with CS has been successful in reducing MR in most of the patients, but with a high mortality rate. Randomized controlled trials of TEER for MR and CS are needed.

show abstract

“…There were 7 case series and 5 observational studies. [11][12][13][18][19][20][21][22][23][24][25][26][27] We included a total population of 4060 CS patients who underwent TEER.…”

Section: Resultsmentioning

confidence: 99%

“…After excluding another 74 records based on article type, a total of 12 studies were included in the meta‐analysis (Figure 1). There were 7 case series and 5 observational studies 11–13,18–27 . We included a total population of 4060 CS patients who underwent TEER.…”

Section: Resultsmentioning

confidence: 99%

Transcatheter edge‐to‐edge mitral valve repair for mitral regurgitation in patients with cardiogenic shock: A systematic review and meta‐analysis

Saito,

Kuno,

Ueyama

et al. 2023

Cathet Cardio Intervent

View full text Add to dashboard Cite

show abstract

“…There were a few urgent procedures that were performed on patients with acute cardiogenic shock. [ 17 ] One patient had a single leaflet detachment that was successfully managed with stabilization using additional clips. [ 18 ] Only one patient required mitral valve surgery.…”

Section: Discussionmentioning

confidence: 99%

Transcatheter Mitral Valve Repair with Mitraclip®

Al-Asmi,

Kaddoura,

Abdelghani

et al. 2023

Heart Views

Self Cite

View full text Add to dashboard Cite

Background: Transcatheter mitral valve repair (TMVr), using MitraClip®, is a safe and effective procedure for severe mitral valve regurgitation (MR). However, the therapeutic results of MitraClip® in Qatar remain to be elucidated. A total of 25 patients (mean age 60 ± 14.5 years, 64% males) with symptomatic severe MR and prohibitive surgical risks were enrolled in this study. The procedural success rate was 92% to achieve mild residual MR. There was no periprocedural death. All patients experienced significant improvement in heart failure symptoms and MR grade postprocedure with sustained improvement over 1-year follow-up. Conclusion: The TMVr procedure using the MitraClip® device was safe and resulted in meaningful and sustained functional status and echocardiographic parameter improvement.

show abstract

MitraClip to the Rescue in Cardiogenic Shock

Cited by 2 publications

References 14 publications

Transcatheter edge‐to‐edge mitral valve repair for mitral regurgitation in patients with cardiogenic shock: A systematic review and meta‐analysis

Transcatheter edge‐to‐edge mitral valve repair for mitral regurgitation in patients with cardiogenic shock: A systematic review and meta‐analysis

Transcatheter Mitral Valve Repair with Mitraclip®

Contact Info

Product

Resources

About